Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity

Yasmina Mozo, Beatriz Ruz-Caracuel, Luisa Sisinni et al.|Pediatric Hematology and Oncology|2021

Cited by 28